Probiotic lactobacillus reuteri RC-14 and lactobacillus rhamnosus GR-1 for prevention of urinary tract infections in catheterization-dependent girls with spina bifida

Michael Hsieh,Erika Munch,Gregor Reid,David Roth,Barbara Trautner,Sheldon Kaplan,Eric Jones,James Versalovic
DOI: https://doi.org/10.1016/j.jpurol.2009.02.067
IF: 1.921
2009-04-01
Journal of Pediatric Urology
Abstract:PurposeUrinary tract infections (UTI) represent a significant source of morbidity for boys and girls with spina bifida. In girls, uropathogens originating from the gut migrate through the vagina in order to ascend the urinary tract. The rate of bacteriuria among catheterization-dependent children with spina bifida is at least 40-80%, with many patients experiencing multiple episodes of UTI in association with bacteriuria. Clinical trials have suggested that oral ingestion of probiotic strains, such as L. reuteri RC-14 and L. rhamnosus GR-1, results in normalization of the vaginal microbiota and reduced risk of UTI in women. However, no studies have been carried out on catheterized girls.Material and MethodsWe conducted an open label, pilot clinical trial of orally administered RC-14 and GR-1 (2x109 cfu of each daily) in catheterization-dependent girls with spina bifida.ResultsNine subjects were recruited for the study, with a mean age of 5.3 years. 2 of 9 subjects had pre-existing, asymptomatic bacteriuria. After 3 months of taking the probiotics, one subject demonstrated clearance of bacteriuria, whereas the other continued to have bacteriuria. Of the other seven subjects, all developed bacteriuria at least once. Only one subject had a symptomatic, febrile UTI during a total of 109 patient-weeks of follow-up, which was less than expected based upon previous records of the patients. No adverse effects associated with probiotic use were observed.ConclusionsIn conclusion, orally ingested L. reuteri RC-14 and L. rhamnosus GR-1 were well-tolerated by the children. The three month use of prophylactic probiotic lactobacilli did not appear to reduce acquisition of bacteriuria in girls, but may have prevented episodes of symptomatic UTI. We are currently planning a randomized clinical trial to further test this hypothesis.
pediatrics,urology & nephrology
What problem does this paper attempt to address?